COMMUNIQUÉS West-GlobeNewswire

AnewHealth Announces Strategic Growth Investments from Linden Capital Partners and Nautic Partners
02/11/2026
Leading healthcare investors with deep pharmacy expertise partner with AnewHealth to accelerate clinical innovation and expand individualized care for people with complex medical needs. MOORESTOWN, N.J., Nov. 02, 2026 ( [...]
Family-Run Protocol Health Brings Its Physician-Led Care Nationwide Through Protocol MD, Offering GLP-1 Weight Loss, Peptide Therapy and Bloodwork Online in All 50 States
02/11/2026
Founded by cousins Dr. Richard Dentico, a board-certified physiatrist, and Joe Garvey, the Scarsdale, New York practice extends the care it built in person to patients nationwide, from the first assessment through every [...]
Pamela Anderson announced as keynote speaker for BC Women’s Health Foundation’s 2027 Illuminations Luncheon
02/11/2026
The B.C.-born actress, author, philanthropist and mother will return home for a candid conversation about transformation, reinvention, aging and women’s health this International Women’s Day VANCOUVER, British Columbia [...]
Transactions under Novonesis’ share buyback program
02/11/2026
Please read the announcement in PDF Attachment 2026_26_Share_buyback
Quiet Communities Launches Free Science-based Resource Hub to Help Communities Address Data Center Noise
02/11/2026
Downloadable materials translate public health research and acoustical expertise into practical guidance for addressing noise throughout data center planning, construction and operation LINCOLN, Mass., Nov. 02, 2026 ( [...]
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
02/11/2026
Two Clinical Programs, a 500-Patient Vision, and a November that Could Be a Game-Changer for the Growing Wall Street Story DENVER, Nov. 02, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews.com ) — In a market where the latest [...]
Z Optics Receives Approval to Expand European Clinical Study of the Z+ Virtual Aperture IOL to Canada
02/11/2026
Following exceptional feedback from patients and physicians in Europe, the clinical trial of the Virtual Aperture intraocular lens will now open to clinical sites and patients in Canada RENO, Nev., Nov. 02, 2026 (GLOBE [...]
Coloplast A/S Announcement no. 10/2026 - Coloplast announces revised financial ambition towards 2030 and FY 2026/27 guidance
02/11/2026
Announcement no. 10/2026 Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin 1 in constant currencies in the mid-20% range over the period. Return on [...]
Coloplast A/S Announcement no. 11/2026 - 2025/26 Full-Year Financial Results
02/11/2026
1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth 1 in constant currencies was 0% and includes negative [...]
Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
02/11/2026
China Resources Medical Devices to serve as exclusive distributor for Baird’s microwave ablation (MWA) products in 19 markets in the PRC Agreement includes initial purchase order of RMB 6 million ($900,000) NEW YORK, [...]
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
02/11/2026
The study targets earlier detection, prevention and treatment of Parkinson’s disease, Alzheimer’s disease and other neurodegenerative conditions including rare dementias FREMONT, Calif. and HELSINKI, Finland, Nov. 02, [...]
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry
02/11/2026
First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone. GAMEFILM data highlight high prevalence of [...]
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
02/11/2026
WILMETTE, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026
02/11/2026
Five presentations will highlight new analyses of linerixibat in cholestatic pruritus associated with primary biliary cholangitis, including an oral presentation and four posters from the Phase 3 GLISTEN study and real- [...]
CytomX Therapeutics to Present at Upcoming November Investor Conferences
02/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will [...]
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026
02/11/2026
FLORHAM PARK, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
02/11/2026
ZUG, Switzerland and BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced the appointment of Sivakesava (Siva) Sakhamuri, Ph.D., as Chief Technical Officer, effective immediately [...]
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
02/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Eyconis to Participate in Upcoming Investor Conferences
02/11/2026
REDWOOD CITY, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Eyconis, Inc., a clinical-stage biotechnology company advancing next-generation, long-acting ophthalmic therapeutics, today announced that members of its [...]

Pages